Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
Authors
Keywords
-
Journal
Gut and Liver
Volume 11, Issue 5, Pages 590-603
Publisher
The Editorial Office of Gut and Liver
Online
2017-05-11
DOI
10.5009/gnl16215
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
- (2016) Patrick Marcellin et al. GASTROENTEROLOGY
- Looking into the crystal ball: biomarkers for outcomes of HBV infection
- (2016) Hung-Chih Yang et al. Hepatology International
- Hepatitis B virus: new therapeutic perspectives
- (2016) Chih-Lin Lin et al. LIVER INTERNATIONAL
- Sequential Combination Therapy with Pegylated Interferon Leads to Loss of Hepatitis B Surface Antigen and Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Entecavir Treatment
- (2015) Guo-Jun Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study)
- (2015) Willem Pieter Brouwer et al. HEPATOLOGY
- O116 : Predictive value of baseline and on-treatment qHBsAg level in HBeAg positive CHB patients who switched from NUCs to pegylated interferon A-2A: A further analysis from new switch study
- (2015) P. Hu et al. JOURNAL OF HEPATOLOGY
- O112 : HBsAg clearance after addition of 48 weeks of pegifn in HBeAg negative CHB patients on nucleos(T)ide therapy with undetectable hbvdna for at least one year: final results from ANRS-HB06 pegan study: multicenter randomized controlled phase III trial
- (2015) M. Bourliere et al. JOURNAL OF HEPATOLOGY
- Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
- (2015) Patrick Marcellin et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B
- (2014) Q. Xie et al. CLINICAL INFECTIOUS DISEASES
- Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)
- (2014) Qin Ning et al. JOURNAL OF HEPATOLOGY
- O113 COMBINATION THERAPY WITH PEGINTERFERON ALFA-2a AND A NUCLEOS(T)IDE ANALOGUE FOR HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS: RESULTS OF A LARGE, RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
- (2014) W.-W. Su et al. JOURNAL OF HEPATOLOGY
- P1067 RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)
- (2014) J. Hou et al. JOURNAL OF HEPATOLOGY
- Combination therapy of interferon and nucleotide/nucleoside analogues for chronic hepatitis B
- (2014) G. L.-H. Wong et al. JOURNAL OF VIRAL HEPATITIS
- Optimal therapy for chronic hepatitis B: hepatitis B virus combination therapy?
- (2014) Jorg Petersen et al. LIVER INTERNATIONAL
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
- (2014) J. Lucifora et al. SCIENCE
- Improving clinical outcomes of chronic hepatitis B virus infection
- (2014) Tung-Hung Su et al. Expert Review of Gastroenterology & Hepatology
- Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with peginterferon alfa-2a and adefovir
- (2013) R Bart Takkenberg et al. ANTIVIRAL THERAPY
- Combination therapy with a nucleos(t)ide analogue and interferon for chronic hepatitis B: simultaneous or sequential
- (2013) Masaru Enomoto et al. JOURNAL OF GASTROENTEROLOGY
- 758 ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT
- (2013) C.-J. Liu et al. JOURNAL OF HEPATOLOGY
- Reduction of HBV replication prolongs the early immunological response to IFNα therapy
- (2013) Anthony T. Tan et al. JOURNAL OF HEPATOLOGY
- Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study
- (2013) Z. Huang et al. JOURNAL OF VIRAL HEPATITIS
- A randomized controlled trial of sequential peginterferon-alpha and telbivudine or vice versa for 48 weeks in HBeAg-negative chronic hepatitis B
- (2012) Paola Piccolo et al. ANTIVIRAL THERAPY
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
- (2012) Tai–Chung Tseng et al. GASTROENTEROLOGY
- Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
- (2012) Carolina Boni et al. GASTROENTEROLOGY
- Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B
- (2012) Pietro Lampertico et al. GUT
- Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
- (2012) Quan Yuan et al. GUT
- IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
- (2012) Laura Belloni et al. JOURNAL OF CLINICAL INVESTIGATION
- Dissecting the divergent effects of interferon-alpha on immune cells: Time to rethink combination therapy in chronic hepatitis B?
- (2012) Robert Thimme et al. JOURNAL OF HEPATOLOGY
- The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus
- (2012) Tassilo Volz et al. JOURNAL OF HEPATOLOGY
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B
- (2012) Lorenzo Micco et al. JOURNAL OF HEPATOLOGY
- Sustained efficacy of adefovir add-on therapy in chronic hepatitis B patient with a poor virological response to peginterferon alfa
- (2012) Yun-Xia Wang et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Serum Hepatitis B Surface Antigen Levels Predict Surface Antigen Loss in Hepatitis B e Antigen Seroconverters
- (2011) Tai–Chung Tseng et al. GASTROENTEROLOGY
- Hepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice
- (2011) Marc Lütgehetmann et al. GASTROENTEROLOGY
- Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review
- (2011) Yun-Fan Liaw HEPATOLOGY
- Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
- (2011) Tai-Chung Tseng et al. HEPATOLOGY
- Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report
- (2011) Henry Lik-Yuen Chan et al. JOURNAL OF HEPATOLOGY
- The Hepatitis B e antigen (HBeAg) targets and suppresses activation of the Toll-like receptor signaling pathway
- (2011) Tali Lang et al. JOURNAL OF HEPATOLOGY
- An early decrease in serum HBeAg titre is a strong predictor of virological response to entecavir in HBeAg-positive patients
- (2011) X. Zhang et al. JOURNAL OF VIRAL HEPATITIS
- Serum HBsAg quantification to predict response to peginterferon therapy of e antigen positive chronic hepatitis B
- (2010) H. L.-Y. Chan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
- (2010) Tung-Hung Su et al. ANTIVIRAL THERAPY
- Hepatitis B Surface Antigen Serum Levels Help to Distinguish Active From Inactive Hepatitis B Virus Genotype D Carriers
- (2010) Maurizia Rossana Brunetto et al. GASTROENTEROLOGY
- A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
- (2010) Henry Lik-Yuen Chan et al. HEPATOLOGY
- Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
- (2010) Hiromitsu Kumada et al. HEPATOLOGY RESEARCH
- Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on Asia
- (2010) Tin Nguyen et al. JOURNAL OF HEPATOLOGY
- Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspective
- (2010) Jerzy Jaroszewicz et al. JOURNAL OF HEPATOLOGY
- Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection
- (2010) Dimitra Peppa et al. PLoS Pathogens
- A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B
- (2009) Paola Piccolo et al. ANTIVIRAL THERAPY
- Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a
- (2009) Patrick Marcellin et al. GASTROENTEROLOGY
- Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
- (2008) Rami Moucari et al. HEPATOLOGY
- Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B
- (2008) Maurizia Rossana Brunetto et al. HEPATOLOGY
- HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
- (2008) Michael W. Fried et al. HEPATOLOGY
- Hepatitis B virus surface antigen impairs myeloid dendritic cell function: a possible immune escape mechanism of hepatitis B virus
- (2008) Marjoleine L. Op den Brouw et al. IMMUNOLOGY
- Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
- (2008) Abhishek Das et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More